Cohen Capital Management Inc. Grows Stock Holdings in CME Group Inc. (NASDAQ:CME)

Cohen Capital Management Inc. lifted its stake in CME Group Inc. (NASDAQ:CME) by 31.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,918 shares of the financial services provider’s stock after purchasing an additional 696 shares during the quarter. Cohen Capital Management Inc.’s holdings in CME Group were worth $644,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in CME. Norden Group LLC bought a new stake in CME Group during the 1st quarter valued at about $274,000. Private Advisor Group LLC increased its holdings in CME Group by 3.9% in the 1st quarter. Private Advisor Group LLC now owns 4,592 shares of the financial services provider’s stock worth $989,000 after buying an additional 172 shares in the last quarter. Janney Montgomery Scott LLC raised its position in CME Group by 32.0% in the 1st quarter. Janney Montgomery Scott LLC now owns 52,167 shares of the financial services provider’s stock worth $11,231,000 after buying an additional 12,653 shares during the last quarter. Nordea Investment Management AB lifted its stake in CME Group by 1.4% during the 1st quarter. Nordea Investment Management AB now owns 27,774 shares of the financial services provider’s stock valued at $5,994,000 after acquiring an additional 387 shares during the period. Finally, Salomon & Ludwin LLC purchased a new stake in shares of CME Group during the 1st quarter valued at about $28,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a research report on Tuesday, October 8th. Keefe, Bruyette & Woods lifted their price objective on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Bank of America increased their target price on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a report on Thursday, October 3rd. JPMorgan Chase & Co. upped their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research report on Thursday, July 25th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research note on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus target price of $222.73.

CME Group Stock Performance

NASDAQ:CME opened at $225.00 on Monday. The stock has a 50-day moving average price of $220.69 and a 200 day moving average price of $209.49. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.36. The stock has a market capitalization of $81.02 billion, a P/E ratio of 23.51, a P/E/G ratio of 5.67 and a beta of 0.55.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter last year, the business posted $2.25 earnings per share. Equities research analysts forecast that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Insider Transactions at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. In related news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,221 shares of company stock valued at $3,351,895. 0.30% of the stock is currently owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.